Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Cynthia Mattox

Glaucoma Specialist Boston, MA Medical Doctor

NPI 1194780825 CMS profile 235264

800 Washington St, # 450, Boston, MA 02111

Open in the dashboard

General payments

$90,532

70 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$40,500 paid to institutions, not to them · program years 2019–2021

Through program year 2022, Cynthia Mattox of Boston, MA is reported in the CMS Open Payments database as having received $90,532 across 70 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $40,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Glaucoma Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $5,900 4
2021 General $8,925 5
2020 General $10,325 6
2019 General $65,382 55

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cynthia Mattox
  • Glaucoma Specialist median
  • Middle half of Glaucoma Specialist
  • National median

In program year 2025, general payments to Cynthia Mattox were reported at $0. Among 370 Glaucoma Specialist profiles paid that year, the median was $597 and the middle half received between $244 and $1,607.

Show as a table
Year Cynthia Mattox Glaucoma Specialist median Middle half National median
2019 $65,382 $433 $150–$1,170 $163
2020 $10,325 $242 $74–$693 $114
2021 $8,925 $324 $122–$936 $132
2022 $5,900 $399 $121–$1,081 $149
2023 $0 $458 $190–$1,208 $160
2024 $0 $558 $215–$1,359 $164
2025 $0 $597 $244–$1,607 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Allergan Inc. $40,132 38 payments
  2. Ivantis, Inc $14,211 7 payments
  3. Aerie Pharmaceuticals, Inc. $12,350 2 payments
  4. Glaukos Corporation $10,401 10 payments
  5. New World Medical,Inc. $9,100 7 payments
  6. Alcon Research LLC $2,850 3 payments
  7. Alcon Vision LLC $1,400 1 payment
  8. Carl Zeiss Meditec, Inc. $88 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Consulting Fee $76,750 32 payments
  2. Travel and Lodging $4,597 15 payments
  3. Honoraria $4,250 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,200 2 payments
  5. Food and Beverage $735 19 payments
Products named General payments · program years 2019–2022
  1. XEN $31,097 18 payments
  2. Kahook Dual Blade $9,100 7 payments
  3. Ahmed Glaucoma Valve $9,100 7 payments
  4. Hydrus Microstent $7,175 3 payments
  5. Hydrus $7,036 4 payments
  6. Streamline Surgical System $4,500 2 payments
  7. CyPass $2,850 3 payments
  8. iStent inject Trabecular Micro-Bypass Stent System $2,181 3 payments
  9. iStent Trabecular Micro-Bypass Stent System $2,100 1 payment
  10. LUMIGAN $1,400 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

70 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Glaucoma Specialist in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record